3 unknown, 2 completed. 5 Phase 2, 2 Phase 1.
| Phase | Trials | Status |
|---|---|---|
| Phase 2 | 5 | Unknown 3, Completed 2 |
| Phase 1 | 2 | Unknown 2 |
Follow Hepatic Carcinoma: new trials by email Literature Review of Hepatic Carcinoma trials Research Report on Hepatic Carcinoma
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Efficacy and Safety of Octreotide in Laparoscopic Hepatectomy Surgery: Effect on Blood Loss, Need for Vasoactive Drugs, Transfusion Requirements. Octreotide, Placebo - Hepatic Carcinoma, Hepatic Metastasis | Phase 2 | Unknown | Clinica Universidad de Navarra, Universidad de Navarra | 62 | 2023-08-14 | 2023-10-17 |
| to Assess the Accuracy and Reliability of the Ga68-Dolacga Positron Emission Tomography Compared to Computer Tomography Volumetry and Indocyanine Green Retention Test for Measurement of Liver Reserve Ga68-Dolacga Injection - Hepatic Carcinoma | Phase 2 | Completed | National Atomic Research Institute, Taiwan | 30 | 2021-12-14 | 2023-12-13 |
| A Clinical Study in Patients With High-risk Recurrent Primary Hepatocellular Carcinoma Using Autologous TILs Tumor infiltrating lymphocyte - Hepatic Carcinoma | Phase 1 / Phase 2 | Unknown | CAR-T (Shanghai) Cell Biotechnology Co., Ltd. | 40 | 2020-08-26 | 2020-09-04 |
| Transarterial Chemoembolization in Combination With Nivolumab Performed for Intermediate Stage Hepatocellular Carcinoma Nivolumab, TACE - Carcinoma, Hepatocellular, Hepatic Carcinoma | Phase 2 | Completed | AIO-Studien-gGmbH | 49 | 2018-06-14 | 2023-07-20 |
| A Clinical Research of CAR T Cells Targeting EpCAM Positive Cancer CAR-T cell immunotherapy - Colon Cancer, Esophageal Carcinoma | Phase 1 / Phase 2 | Unknown | First Affiliated Hospital of Chengdu Medical College | 60 | 2017-01-01 | 2017-01-06 |
Carcinoma, Hepatocellular (5) · Colonic Neoplasms (1) · Esophageal Neoplasms (1) · Liver Neoplasms (1) · Pancreatic Neoplasms (1) · Prostatic Neoplasms (1) · Stomach Neoplasms (1)
Adenocarcinoma (5) · Carcinoma (5) · Digestive System Diseases (5) · Digestive System Neoplasms (5) · Liver Diseases (5) · Neoplasms (5) · Neoplasms by Histologic Type (5) · Neoplasms by Site (5) · Neoplasms, Glandular and Epithelial (5) · Liver Neoplasms (4) · Colonic Diseases (1) · Colorectal Neoplasms (1) · Endocrine Gland Neoplasms (1) · Endocrine System Diseases (1) · Esophageal Diseases (1)
Immunotherapy, Adoptive (1) · Nivolumab (1) · Octreotide (1)
AIO-Studien-gGmbH (1) · CAR-T (Shanghai) Cell Biotechnology Co., Ltd. (1) · Clinica Universidad de Navarra, Universidad de Navarra (1) · First Affiliated Hospital of Chengdu Medical College (1) · National Atomic Research Institute, Taiwan (1)
China (2) · Germany (1) · Spain (1) · Taiwan (1)
Arndt Vogel, Prof.Dr. (1) · Wei-Chen Lee, MD (1) · Xiao-an Li, PhD (1)
2017 (1)